Features and outcomes of patients who underwent cardiac device deactivation

JAMA Internal Medicine

Volumn 174, Issue 1, 2014, Pages 80-85

  Buchhalter, Lillian C ^a   Ottenberg, Abigale L ^b   Webster, Tracy L ^b   Swetz, Keith M ^b   Hayes, David L ^b   Mueller, Paul S ^b  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRADYCARDIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICE DEACTIVATION; CARDIOVASCULAR MORTALITY; CONSULTATION; EBSTEIN ANOMALY; ETHICS; FEMALE; FIELD SALES REPRESENTATIVE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LIVING WILL; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL RECORD REVIEW; MIDDLE AGED; MULTIPLE ORGAN FAILURE; NEUROLOGIC DISEASE; NURSE; OUTCOME ASSESSMENT; PACEMAKER; PALLIATIVE THERAPY; PARAMEDICAL PERSONNEL; PHYSICIAN; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; TACHYCARDIA; VENTRICULAR ASSIST DEVICE; VERY ELDERLY;

ADVANCE CARE PLANNING; AGED; AGED, 80 AND OVER; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; PACEMAKER, ARTIFICIAL; RETROSPECTIVE STUDIES; TERMINAL CARE; WITHHOLDING TREATMENT;

EID: 84892383457     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.11564     Document Type: Article

References (31)

1. Goldberger Z, Lampert R. Implantable cardioverter-defibrillators: expanding indications and technologies. JAMA. 2006;295(7):809-818.
2. Roger VL, Go AS, Lloyd-Jones DM, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2012 update: a report from the American Heart Association. Circulation. 2012;125(1):e2-e220.
3. Mond HG, Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009: a World Society of Arrhythmia's project. Pacing Clin Electrophysiol. 2011;34(8):1013-1027.
4. Wilkoff BL, Auricchio A, Brugada J., et al.; Heart Rhythm Society (HRS); European Heart Rhythm Association (EHRA); American College of Cardiology (ACC); American Heart Association (AHA); European Society of Cardiology (ESC); Heart Failure Association of ESC (HFA); Heart Failure Society of America (HFSA). HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations: developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart Failure Society of America (HFSA). Endorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered branch of the ESC), the American College of Cardiology, the American Heart Association. Europace. 2008;10(6):707-725.
5. Lampert R, Hayes DL, Annas G.J., et al.; American Heart Association; American College of Cardiology; American Geriatrics Society; American Academy of Hospice and Palliative Medicine; European Heart Rhythm Association; Hospice and Palliative Nurses Association. HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy. Heart Rhythm. 2010;7(7):1008-1026.
6. Mueller PS, Jenkins SM, Bramstedt K.A., Hayes DL Deactivating implanted cardiac devices in terminally ill patients: practices and attitudes. Pacing Clin Electrophysiol. 2008;31(5):560-568.
7. Kapa S, Mueller PS, Hayes D.L., Asirvatham SJ Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients. Mayo Clin Proc. 2010;85(11):981-990.
8. Kelley AS, Reid MC, Miller D.H., Fins JJ, Lachs MS Implantable cardioverter-defibrillator deactivation at the end of life: a physician survey. Am Heart J. 2009;157(4):702-708, e1.
9. Marinskis G, van Erven L; EHRA Scientific Initiatives Committee. Deactivation of implanted cardioverter-defibrillators at the end of life: results of the EHRA survey. Europace. 2010;12(8):1176-1177.
10. Sherazi S, Daubert JP, Block R.C., et al Physicians' preferences and attitudes about end-of-life care in patients with an implantable cardioverter-defibrillator. Mayo Clin Proc. 2008;83(10):1139-1141.
11. Goldstein N, Bradley E, Zeidman J., Mehta D, Morrison RS Barriers to conversations about deactivation of implantable defibrillators in seriously ill patients: results of a nationwide survey comparing cardiology specialists to primary care physicians. J Am Coll Cardiol. 2009;54(4):371-373.
12. Korantzopoulos P, Letsas KP, Grekas G, Goudevenos JA Pacemaker dependency after implantation of electrophysiological devices. Europace. 2009;11(9):1151-1155.
13. Mueller PS. Clinicians' views regarding deactivation of cardiovascular implantable electronic devices in seriously ill patients. Heart Rhythm. 2010;7(11):1543-1544.
14. Bevins MB. The ethics of pacemaker deactivation in terminally ill patients. J Pain Symptom Manage. 2011;41(6):1106-1110.
15. Kay GN, Bittner GT Response to Zellner et al. Circ Arrhythm Electrophysiol. 2009;2:336-339.
16. Minn Rev Stat. § 144.295.
17. Frost DW, Cook DJ, Heyland D.K., Fowler RA Patient and healthcare professional factors influencing end-of-life decision-making during critical illness: a systematic review. Crit Care Med. 2011;39(5):1174-1189.
18. Neb Rev Stat. § 20-404.
19. Huddle TS, Amos Bailey F. Pacemaker deactivation: withdrawal of support or active ending of life? Theor Med Bioeth. 2012;33(6): 421-433.
20. Mueller PS, Hook CC, Hayes DL Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life. Mayo Clin Proc. 2003;78(8):959-963.
21. Torke AM, Siegler M, Abalos A., Moloney RM, Alexander GC Physicians' experience with surrogate decision making for hospitalized adults. J Gen Intern Med. 2009;24(9):1023-1028.
22. Silveira MJ, Kim SY, Langa KM Advance directives and outcomes of surrogate decision making before death. N Engl J Med. 2010;362(13):1211-1218.
23. Mueller PS, Hook CC, Fleming KC Ethical issues in geriatrics: a guide for clinicians. Mayo Clin Proc. 2004;79(4):554-562.
24. Tajouri TH, Ottenberg AL, Hayes D.L., Mueller PS The use of advance directives among patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2012;35(5):567-573.
25. Tajouri TH, Ottenberg AL, Mueller PS The prevalence and use of advance directives among patients with pacemakers. Heart Rhythm. 2010;7(5):S192.
26. Goldstein NE, Mehta D, Siddiqui S., et al. "That's like an act of suicide," patients' attitudes toward deactivation of implantable defibrillators. J Gen Intern Med. 2008;23(SUPPL. 1):7-12.
27. Lewis WR, Luebke DL, Johnson N.J., Harrington MD, Costantini O, Aulisio MP Withdrawing implantable defibrillator shock therapy in terminally ill patients. Am J Med. 2006;119(10):892-896.
28. Goldstein NE, Lampert R, Bradley E., Lynn J, Krumholz HM Management of implantable cardioverter defibrillators in end-of-life care. Ann Intern Med. 2004;141(11):835-838.
29. Goldstein N, Carlson M, Livote E., Kutner JS Brief communication: Managementofimplantable cardioverter-defibrillators in hospice: a nationwide survey. Ann Intern Med. 2010;152(5):296-299.
30. Dodson JA, Fried TR, Van Ness PH, Goldstein NE, Lampert R. Patient preferences for deactivation of implantable cardioverter-defibrillators. JAMA Intern Med. 2013;173(5):377-379.
31. Sherazi S, McNitt S, Aktas M.K., et al End-of-life care in patients with implantable cardioverter defibrillators: a MADIT-II Substudy [published online June 3, 2013]. Pacing Clin Electrophysiol. 2013.